根据最近的SEC文件显示，Catalent, Inc. (NYSE:CTLT)的董事Ryan Michelle R近期出售了2,800股公司普通股。每股售价为59.70美元，总交易价值为167,160美元。此次出售后，Ryan Michelle R现持有10,835股，包括限制性股票单位。这些股票的出售是为了支付之前根据Catalent非雇员董事薪酬计划授予的限制性股票单位相关的税款。

The Eu­ro­pean Com­mis­sion is ask­ing bio­phar­ma and man­u­fac­tur­ing com­pa­nies about their re­ac­tion to No­vo ...

EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...

A summary of current health news details EU regulators probing Novo Nordisk's $16.5 billion Catalent takeover, Amgen's ...

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...